## IEX: IDEX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.6% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($171.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Will a New CFO With M&A Roots Reshape IDEX's (IEX) Capital Allocation Narrative?**
- Source: Simply Wall Street | 20251214T020802 | Neutral | Relevance: 100%
- IDEX Corporation has appointed Sean M. Gillen as their new CFO, effective January 5, 2026, bringing his capital markets and M&A experience to the company. This change in leadership could significantly influence IDEX's future capital allocation decisions, especially concerning its existing investment narrative, dividend policy, and efforts to manage tariff costs. Investors will be watching to see how his background reshapes the company's financial strategy amid ongoing market challenges.

**2. Will a New CFO With M&A Roots Reshape IDEX's (IEX) Capital Allocation Narrative?**
- Source: Simply Wall Street | 20251214T014200 | Neutral | Relevance: 100%
- IDEX Corporation has appointed Sean M. Gillen as their new CFO, effective January 5, 2026. Gillen's background in capital markets and M&A experience is expected to influence future capital allocation decisions, potentially reshaping IDEX's investment narrative. The company continues its dividend approval and cost-saving initiatives despite challenges from tariffs and softer demand in some sectors.

**3. Curi Capital LLC Purchases 23,510 Shares of IDEX Corporation $IEX**
- Source: MarketBeat | 20251213T104946 | Bullish | Relevance: 100%
- Curi Capital LLC increased its stake in IDEX Corporation (NYSE:IEX) by 29.7% in the second quarter, acquiring an additional 23,510 shares and bringing its total holdings to 102,789 shares valued at $18.047 million. Several other institutional investors also modified their holdings, with 97.96% of the stock currently owned by institutional investors and hedge funds. Analysts have issued a "Moderate Buy" consensus rating for IDEX with a target price of $196.86.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $202 | $197 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.10M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Wellington Managemen: 8.6% (+3.4%)
- Blackrock Inc.: 7.6% (-1.8%)
- Morgan Stanley: 4.5% (+7.6%)
- State Street Corpora: 4.2% (+1.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 21.5x stretched relative to 5% growth. Balance sheet: strong liquidity (2.9x). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.5B |
| Beta | 1.00 |
| 52W Range | $153.36 - $226.05 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 21.5 |
| Current P/E | 22.6 |
| YoY Growth | 5.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.6% to 3.6% (+4.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >4.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. AM_20 at 3.3% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.57% (CS: 64) | Neutral |
| RSI_14 | 61.2 | Neutral |
| MACD Histogram | 0.39 | Bullish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.054x | Above |
| vs SMA200 | 1.032x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $178.69
- **Stop Loss:** $171.61 (4.0% risk)
- **Target:** $185.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 169
- **Position Value:** $30,198.61
- **Portfolio %:** 30.20%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.93 | $2.03 | +5.2% |
| 2025Q2 | $1.99 | $2.07 | +4.0% |
| 2025Q1 | $1.64 | $1.75 | +6.7% |
| 2024Q4 | $2.03 | $2.04 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*